SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
___________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) of the
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): October 10, 2006
MEDICAL
DISCOVERIES, INC.
(Exact
name of registrant as specified in charter)
|
Utah
|
0-12627
|
87-0407858
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
|
1338
S. Foothill Drive, #266, Salt Lake City, Utah
84108
(Address
of principal executive offices)
|
|
Registrant’s
telephone number, including area code: (801)
582-9583
|
|
(Former
name or former address, if changed since last report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
5.02. Appointment
of Directors.
At
a
meeting of the Board of Directors of Medical Discoveries, Inc. (the “Company”)
on October 10, 2006, the Board approved an expansion of the Board from three
to
five members and filled the resulting vacancies with Verdis Norton and Jody
Olson.
Mr.
Norton has over 25 years of management experience including senior positions
at
Kraft General Foods and Kraft Food Corporation in sales, marketing, general
management and strategic planning. Most recently, Mr. Norton was President
of
aLF Ventures LLC, an emerging biotechnology company that introduced Activated
Lactoferrin (Activin(TM)), a food safety technology that protects consumers
from
harmful bacteria.
Mr.
Olson
was Vice President of Corporate Development at Trus Joist, a $1 billion Boise,
Idaho-based specialty building products company. He has served for many years
as
Chairman of the Board of the State of Idaho Public Employee Retirement System,
a
$10 billion pension fund. Mr. Olson is a member of the Board of Advisors of
venture capital fund Galen Associates New York City, and is a Board member
of
the Council of Institutional Investors (CII) Washington, DC.
Mr.
Olson
is expected to be elected to the Company’s audit committee and to chair that
committee. Messrs. Olson and Norton will both stand for re-election at the
Company’s next annual meeting of shareholders.
SIGNATURES
Pursuant
to
the requirements of the Securities Exchange Act of 1934, the registrant has
duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
| |
MEDICAL
DISCOVERIES, INC. |
|
|
|
| Date: October
12, 2006 |
By: |
/s/ Judy
M. Robinett |
| |
Judy
M. Robinett |
| |
President
and CEO
|
3